Header Logo

Connection

MARGARET SPITZ to Urinary Bladder Neoplasms

Back to Details
This is a "connection" page, showing publications MARGARET SPITZ has written about Urinary Bladder Neoplasms.
MARGARET SPITZ
Connection Strength
1.089
Urinary Bladder Neoplasms
  1. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol. 2007 Nov 01; 25(31):4974-81.
    View in: PubMed
    Score: 0.196
  2. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79.
    View in: PubMed
    Score: 0.174
  3. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):606-9.
    View in: PubMed
    Score: 0.047
  4. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet. 2006 Sep; 70(3):240-5.
    View in: PubMed
    Score: 0.045
  5. Bladder cancer risk as modified by family history and smoking. Cancer. 2006 Aug 15; 107(4):705-11.
    View in: PubMed
    Score: 0.045
  6. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5.
    View in: PubMed
    Score: 0.042
  7. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1832-6.
    View in: PubMed
    Score: 0.042
  8. Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Carcinogenesis. 2005 Oct; 26(10):1741-7.
    View in: PubMed
    Score: 0.041
  9. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):878-84.
    View in: PubMed
    Score: 0.041
  10. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005; 53(2):144-51.
    View in: PubMed
    Score: 0.040
  11. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):379-89.
    View in: PubMed
    Score: 0.040
  12. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):330-8.
    View in: PubMed
    Score: 0.040
  13. Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec; 134(12):3362-9.
    View in: PubMed
    Score: 0.040
  14. Methyl-CpG-binding domain 2: a protective role in bladder carcinoma. Cancer. 2004 May 01; 100(9):1853-8.
    View in: PubMed
    Score: 0.038
  15. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004 Sep; 25(9):1639-47.
    View in: PubMed
    Score: 0.038
  16. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.037
  17. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res. 2003 Apr 20; 536(1-2):131-7.
    View in: PubMed
    Score: 0.036
  18. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003 Apr 02; 95(7):540-7.
    View in: PubMed
    Score: 0.036
  19. Death receptor 4 and bladder cancer risk. Cancer Res. 2003 Mar 15; 63(6):1157-9.
    View in: PubMed
    Score: 0.036
  20. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.